This change in cytokine activity according to the disease course of pulmonary TB is unlikely due to major defects in IFN-γ itself, since mutations in this molecule and its receptors are known to implicate rare severe infections to otherwise poorly pathogenic mycobacteria [41,42]. The gene discussed is IFNG; the disease is pulmonary tuberculosis.